Independent GLP-1 & semaglutide coverage
Clear, sourced information on semaglutide and GLP-1 medications
Product comparisons, industry news, and regulatory tracking for Ozempic, Wegovy, Mounjaro, and the broader GLP-1 category — written for readers who want the sourcing, not the hype. Not a pharmacy. Not medical advice.
Product Reviews
Comparisons and device breakdowns for GLP-1 medications.
Inside the 'Research Peptide' Market: How the Business Model Works, and Where the Gray Areas Are
A growing number of direct-to-consumer sites sell GLP-1 analogs and other peptides labeled 'for research use only.' Here's how that label functions legally, and what it doesn't tell you.
7 min read
Wegovy vs. Zepbound: How the Two Leading Weight-Management Drugs Compare
A single-hormone agonist against a dual-hormone agonist. Here's what separates Novo Nordisk's Wegovy from Eli Lilly's Zepbound on paper.
6 min read
Ozempic vs. Wegovy: What Actually Differs Between the Two Semaglutide Brands
Same active ingredient, different approved uses, different dosing schedules. Here's a side-by-side look at how Novo Nordisk's two semaglutide products compare.
7 min readNews & Insights
What's moving in the GLP-1 industry — pipeline, coverage, supply.
What Novo Nordisk's Earnings Reports Actually Reveal About GLP-1 Demand
Novo Nordisk breaks out sales for Ozempic, Wegovy, and Rybelsus in its quarterly filings. Here's how to read those numbers without over-interpreting them.
5 min read
Where Semaglutide Stands on the FDA Drug Shortage List
A running summary of how the FDA has classified semaglutide injection availability, and why the shortage designation has downstream effects on compounding.
5 min read
Novo Nordisk Sues Eli Lilly Over Obesity-Drug Advertising Claims
Novo says it's seeking a court order forcing Lilly to pull ads for its obesity drugs and run a corrective campaign. Here's what's actually being alleged.
5 min readPolicy & Regulation
How the US, EU, and China regulate GLP-1 medications.
How the FDA's Compounding Exemption Law Actually Works
Federal law allows pharmacy compounding under specific exemptions from standard drug approval requirements. Here's the legal structure behind that exemption.
6 min read
State-by-State Telehealth Prescribing Rules for GLP-1 Drugs
Telemedicine practice standards are set at the state level in the U.S., which means the rules governing a GLP-1 telehealth prescription can change at a state line.
6 min read
Canada: Health Canada Approval and Provincial Coverage Differences
Health Canada approves GLP-1 drugs nationally, but public drug coverage is administered provincially, creating access differences similar to the EU's member-state model.
5 min read